3 terminated, 1 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Terminated 3, Completed 1 |
Follow Hepatopulmonary Syndrome: new trials by email Literature Review of Hepatopulmonary Syndrome trials Research Report on Hepatopulmonary Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Letrozole in Patients With Hepatopulmonary Syndrome Letrozole, Placebo - Hepatopulmonary Syndrome | Phase 2 | Terminated | Mayo Clinic | 1 | 2021-02-18 | 2024-05-14 |
| Sorafenib for Hepatopulmonary Syndrome Sorafenib, Placebo - Hepatopulmonary Syndrome | Phase 2 | Terminated | University of Pennsylvania | 28 | 2014-03-01 | 2019-04-25 |
| Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis bosentan, Placebo - Hepatopulmonary Syndrome, Liver Cirrhosis | Phase 2 | Terminated | Medical University of Vienna | 6 | 2011-10-01 | 2016-09-28 |
| A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome Norfloxacin, Placebo - Hepatopulmonary Syndrome | Phase 2 | Completed | Unity Health Toronto | 9 | 2006-10-01 | 2016-12-07 |
Liver Cirrhosis (1)
Digestive System Diseases (4) · Liver Diseases (4) · Lung Diseases (4) · Respiratory Tract Diseases (4) · Fibrosis (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Bosentan (1) · Letrozole (1) · Norfloxacin (1) · Sorafenib (1)
Mayo Clinic (1) · Medical University of Vienna (1) · Unity Health Toronto (1) · University of Pennsylvania (1)
United States (2) · Austria (1) · Canada (1)
Hilary M DuBrock, MD (1) · Marie Faughnan, MD MSc FRCPC (1) · Steven M Kawut, MD, MS (1) · Valentin H Fuhrmann, MD (1)
UM1HL116886 (1)